Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
Currency:  € $ £
Discounted Reports
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare

Global RNAi Drug Pipeline Analysis

Enquire | Email | Print

Published Date: Oct, 2013
Format: PDF
No of Pages: 250
Select pricing :
Change Currency: € EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

“Global RNAi Drug Pipeline Analysis” by PNS Pharma gives comprehensive insight on the various drugs being developed based upon RNAi technology. Research report covers all the ongoing drugs being developed in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each drug profile in development phase enables the reader to identify and understand the RNAi technology associated with the various diseases.

This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the RNAi Drug market based upon development process. Following parameters for each drug profile in development phase are covered in “Global RNAi Drug Pipeline Analysis” research report:

• Drug Profile Overview
• Alternate Names for Drug
• Active Indication
• Phase of Development
• Mechanism of Action
• Brand Name
• Patent Information
• Orphan Designation by Indication, Country & Organisation
• Country for Clinical Trial
• Owner / Originator/ Licensee/Collaborator
• Administrative Route
• Drug Class
• ATC Codes

Breakup of RNAi Drug by Development Phase:

• Research: 26
• Phase-I: 88
• Phase-I/II: 5
• Phase-II: 10
• Phase-III: 1

1. Global RNAi Drug Market Outlook
1.1 Current Market Scenario
1.2 Key Drivers for Adopting RNAi
1.3 Future Opportunity

2. RNAi Drug Development Phase: Research
2.1 Overview
2.2 RNAi Drug Profile in Development Phase

3. RNAi Drug Development Phase: Preclinical
3.1 Overview
3.2 RNAi Drug Profile in Development Phase

4. RNAi Drug Development Phase: Phase-I
4.1 Overview
4.2 RNAi Drug Profile in Development Phase

5. RNAI Drug Development Phase: Phase:I/II
5.1 Overview
5.2 RNAi Drug Profile in Development Phase

6. RNAi Drug Development Phase: Phase-II
6.1 Overview
6.2 RNAi Drug Profile in Development Phase

7. RNAi Drug Development Phase: Phase-III
7.1 Overview
7.2 RNAi Drug Profile in Development Phase

List of Tables

Each Drug Profile has Tables Representing Following Information:

• Alternate Names
• Originator & Owner
• Collaborator
• Technology Provider
• Licensee(s)
• Highest Development Phase
• Indications
• Class
• Mechanism of action
• WHO & EphMRA ATC code
• Allocated Brand Name & orphan Designation

Related Reports:  


Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.


Top Go to top of the page

product id: 426042, price: INR 91356, PNS Pharma

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
About Trust Online